Messoud Ashina, who serves as a Professor of Neurology and Senior Consultant at the University of Copenhagen, past President of the International Headache Society, and Director of the Human Migraine Research Unit at the Danish Headache Center, Rigshospitalet, received this award in recognition of his research in the field of migraine and molecular medicine. Professor Ian David Hickson, the Director of the Center for Chromosome Stability at the Department of Cellular and Molecular Medicine of the University of Copenhagen, also received the award for his research contributions.
During the award ceremony, Dean Bente Stallknecht welcomed the attendees and introduced the awardees, highlighting Professor Messoud Ashina’s research focus on migraine, a neurological condition that affects over a billion people worldwide. Her remarks emphasized his groundbreaking research on the mechanisms of migraine attacks, including the study of molecular and cellular mechanisms, as well as the identification of functional changes in the brain and blood vessels. His discoveries have led to the development of a promising new treatment targeting the pituitary adenylate-cyclase-activating polypeptide (PACAP), which has shown positive results in Phase II clinical trials. Furthermore, Professor Ashina has played a significant role in advancing knowledge about migraine diagnosis, treatment, and the education of young researchers in the field.
With over 600 publications, abstracts, and books on the pathophysiology of headaches, Professor Ashina’s extensive body of work has greatly contributed to the scientific understanding of migraines and related conditions. His research findings have been published in renowned international medical journals, solidifying his reputation as an influential figure in the field.
Professor Ian David Hickson, renowned for his studies in molecular medicine with a specific focus on DNA damage and repair, was also acknowledged for his research contributions that hold potential for the development of new therapeutic options in cancer treatment and age-related diseases. His research has gained international recognition, including recognition from the UK Royal Society.
During their speeches, both Messoud Ashina and Ian David Hickson expressed their gratitude to the Kirsten and Freddie Johansen Foundation for the prestigious awards. They pledged to continue their dedicated research efforts for the benefit of public health.
The Kirsten and Freddie Johansen Foundation (KFJ) was established on June 21, 2004. From 2006 to 2010, the award was presented annually to a researcher from the Faculty of Health at the University of Copenhagen. In 2011, Kirsten and Freddie Johansen expanded the awards to include one for a preclinical researcher and another for a clinical researcher. Each award carries a research grant of DKK 1.75 million.
In addition to his research accomplishments, Professor Ashina actively contributes to the Azerbaijani diaspora. He was appointed as a member of the Board of Trustees of the YASHAT Foundation and has been awarded the Medal of the Republic of Azerbaijan for his merits in diaspora activities.
